The capsule shell contains hypromellose, purified water, carrageenan, potassium chloride and FDC Yellow 6 (110 Sunset Yellow FCF).
|
|
- Tobias Fitzgerald
- 6 years ago
- Views:
Transcription
1 CONSUMER INFORMATION Pr SEEBRI BREEZHALER Glycopyrronium inhalation powder hard capsules This leaflet is part III of a three-part "Product Monograph" published when SEEBRI BREEZHALER was approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about SEEBRI BREEZHALER. Contact your doctor, nurse, or pharmacist if you have any questions about the drug. PLEASE READ THIS INFORMATION CAREFULLY AND COMPLETELY BEFORE YOU USE Pr SEEBRI BREEZHALER EVEN IF YOU HAVE JUST REFILLED YOUR PRESCRIPTION, SINCE SOME INFORMATION MAY HAVE CHANGED. ABOUT THIS MEDICATION What the medication is used for: SEEBRI BREEZHALER is used long term once daily to treat breathing difficulties due to a lung disease called chronic obstructive pulmonary disease (COPD). It is not for treating sudden, severe symptoms of COPD. What it does: SEEBRI BREEZHALER contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators. In COPD the muscles around the airways tighten, making breathing difficult. SEEBRI BREEZHALER blocks tightening of these muscles in the lungs, making it easier for air to get in and out of the lungs. When you inhale it, it helps you breathe more easily. When it should not be used: Do not use SEEBRI BREEZHALER : If you have a severe allergy to glycopyrronium bromide or any other component of SEEBRI BREEZHALER. Ask your doctor, nurse, or pharmacists if you are unsure. To treat sudden, severe symptoms of COPD such as shortness of breath or wheezing. If you have a lactose or severe milk protein allergy as this product contains lactose. SEEBRI BREEZHALER should not be used in children. COPD does not occur in children. If you are younger than 18 years of age. What the medicinal ingredient is: glycopyrronium bromide. What the nonmedicinal ingredients are: Lactose monohydrate and magnesium stearate. The capsule shell contains hypromellose, purified water, carrageenan, potassium chloride and FDC Yellow 6 (110 Sunset Yellow FCF). What dosage forms it comes in: Clear Orange capsules for oral inhalation. Each capsule contains 63 mcg of glycopyrronium bromide equivalent to 50 mcg of glycopyrronium. Each pack includes an inhaler and capsules (in blister strips) that contain the medicine as inhalation powder. WARNINGS AND PRECAUTIONS BEFORE using SEEBRI BREEZHALER talk to your doctor, nurse, or pharmacist if you: are pregnant or planning to become pregnant; are a breastfeeding mother; have heart problems, such as rapid or irregular heart beat or abnormal electrical signal called prolongation of the QT interval ; are taking any medications including eye drops, this includes medications you can buy without prescription; have an enlarged prostate, problems passing urine or painful urination; have eye problems, such as glaucoma or eye pain, blurred vision, see halos around lights or coloured images; have any allergies to food or drugs; are allergic to lactose (milk sugar); have problems with your kidneys. These capsules are intended for inhalation only. DO NOT SWALLOW. SEEBRI BREEZHALER should not be used more frequently than once daily. Do not exceed the prescribed dose. This medication has been prescribed for you and should not be given to other people. Avoid getting the drug powder into your eyes. This may result in eye pain and/or discomfort, temporary blurring of vision, and/or coloured images in association with red eyes. These may be signs of acute narrow-angle glaucoma. Should any of these symptoms develop, consult a doctor immediately. Remember to tell any other doctor, nurse, dentist or pharmacist you consult that you are taking this medication. Driving and Using Machines: The occurrence of dizziness or blurred vision may influence the ability to drive and use machinery. During the treatment with SEEBRI BREEZHALER, tell your doctor immediately if you experience any of the following symptoms: If you experience a tightness of the chest, coughing, wheezing or breathlessness immediately after inhalation of SEEBRI BREEZHALER (signs of bronchospasm) SEEBRI BREEZHALER Consumer Information Page 1 of 6
2 If you experience difficulties in breathing or swallowing, swelling of tongue, lips and face, hives or itching, skin rash (signs of hypersensitivity reaction). Do not use SEEBRI BREEZHALER again before speaking with your doctor. If your COPD symptoms (breathlessness, wheezing, cough) do not improve or if they worsen during your treatment stop taking SEEBRI BREEZHALER and tell your doctor immediately if you experience eye pain or discomfort, temporary blurring of vision, visual halos or colored images in association with red eyes; these may be signs of an acute attack of narrow-angle glaucoma. SEEBRI BREEZHALER does not relieve sudden symptoms of COPD. Always have a short-acting bronchodilator medicine with you to treat acute symptoms. If you do not have an inhaled, short-acting bronchodilator, contact your healthcare provider to have one prescribed for you. Get emergency medical care if: breathing problems worsen quickly you use your short-acting bronchodilator medicine, but it does not relieve your breathing problems Ask your doctor or pharmacist for advice before taking any additional medicine. INTERACTIONS WITH THIS MEDICATION Tell your doctor, nurse, or a pharmacist if you are taking or have recently taken any other medicines, including prescription and non-prescription drugs, eye drops, vitamins, and herbal supplements. help you to remember to use it. How to inhale SEEBRI BREEZHALER Only use the inhaler contained in this pack (SEEBRI BREEZHALER inhaler) to inhale the powder in a capsule. Do not swallow the capsules. Capsules should always be stored in the blister strip and only removed immediately before use. When you start a new pack, use the new SEEBRI BREEZHALER inhaler supplied in this new pack. Dispose of each inhaler after 30 days of use. How long to continue to take SEEBRI BREEZHALER Keep using SEEBRI BREEZHALER for as long as your doctor tells you. COPD is a long-term disease and you should use SEEBRI BREEZHALER every day and not only when you have breathing problems or other symptoms of COPD. If you have questions about how long to take SEEBRI BREEZHALER, talk to your doctor or pharmacist. Each one of your SEEBRI BREEZHALER pack contains one SEEBRI BREEZHALER inhaler consisting of a cap and a base. one or more blisters containing SEEBRI BREEZHALER capsules to be used in the inhaler It s not recommended to use SEEBRI BREEZHALER with anticholinergics. Especially tell your doctor if you take any of the following as these medicines may interact with SEEBRI BREEZHALER : atropine or other anticholinergics (ipratropium, oxitropium, tiotropium, etc.). PROPER USE OF THIS MEDICATION Always use this medicine exactly as your doctor, nurse, or pharmacist has told you. Check with your doctor, nurse, or pharmacist if you are not sure. You can inhale SEEBRI BREEZHALER before or after food or drink. Usual adult dose: Inhale the contents of one capsule through the mouth each day, everyday at the same time. Use SEEBRI BREEZHALER even when you have no breathing problems or other symptoms of COPD. You only need to inhale once a day to help you breathe easier because SEEBRI BREEZHALER lasts for 24 hours. Taking SEEBRI BREEZHALER at the same time each day will also Only use the SEEBRI BREEZHALER inhaler contained in this pack to inhale the powder in the capsule. Do not use SEEBRI BREEZHALER capsules with any other inhaler. Do not use SEEBRI BREEZHALER inhaler to take any other capsule medicine. Dispose of each inhaler after 30 days. Ask your pharmacist how to dispose of medicines and inhalers no longer required. Do not swallow SEEBRI BREEZHALER capsules. The SEEBRI BREEZHALER Consumer Information Page 2 of 6
3 powder in the capsules is for you to inhale. How to use your SEEBRI BREEZHALER inhaler: Pull off cap. Close the inhaler: Close the inhaler fully. You should hear a click as it fully closes. Pierce the capsule: Open inhaler: Hold the base of the inhaler firmly and tilt the mouthpiece to open the inhaler. Hold the inhaler upright with the mouthpiece pointing up. Press both buttons together firmly at the same time. You should hear a click as the capsule is being pierced. Do not press the piercing buttons more than once. Release the buttons fully. Prepare capsule: Separate one of the blisters from the blister card by tearing along the perforation. Take one blister and peel away the protective backing to expose the capsule. Do not push the capsule through the foil. Remove one SEEBRI BREEZHALER capsule: Capsules should always be stored in the blister and only removed immediately before use. With dry hands, remove the capsule from the blister. Do not swallow the SEEBRI BREEZHALER capsule. Insert capsule: Place the capsule into the capsule chamber. Never place a capsule directly into the mouthpiece. Breathe out: Before placing the mouthpiece in your mouth, breathe out fully. Never blow into the mouthpiece. Inhale the medicine: Before breathing in: Hold the inhaler as shown in the picture with the buttons to the left and right (not up and down). Place the mouthpiece in your mouth and close your lips firmly around the mouthpiece. Breathe in rapidly but steadily, as deeply as you can. Do not press the piercing buttons. SEEBRI BREEZHALER Consumer Information Page 3 of 6
4 Note: As you breathe in through the inhaler, the capsule spins around in the chamber and you should hear a whirring noise. You will experience a sweet taste as the medicine goes into your lungs. If you do not hear a whirring noise, the capsule may be stuck in the capsule chamber. If this occurs, open the inhaler and carefully loosen the capsule by tapping the base of the inhaler. Do not press the piercing buttons to loosen the capsule. Repeat steps 9 and 10 if necessary. Hold breath: Continue to hold your breath for at least 5-10 seconds or as long as comfortably possible while removing the inhaler from your mouth. Then breathe out. Open the inhaler to see if any powder is left in the capsule. If there is powder left in the capsule, close the inhaler and repeat steps 9 to 12. Most people are able to empty the capsule with one or two inhalations. Some people occasionally cough briefly soon after inhaling the medicine. If you do, don t worry, as long as the capsule is empty, you have received the full dose. Remove capsule: After you have finished taking your daily dose of SEEBRI BREEZHALER, open the mouthpiece again, remove the empty capsule by tipping it out of the capsule chamber, and discard it. Close the inhaler and replace the cap. Do not store the capsules in the SEEBRI BREEZHALER inhaler. REMEMBER: Do not swallow SEEBRI BREEZHALER capsules. Only use the SEEBRI BREEZHALER inhaler contained in this pack. SEEBRI BREEZHALER capsules must always be stored in the blister, and only removed immediately before use. Never place a SEEBRI BREEZHALER capsule directly into the mouthpiece of the SEEBRI BREEZHALER inhaler. Do not press the piercing buttons more than once. Never blow into the mouthpiece of the SEEBRI BREEZHALER inhaler. Always release the push buttons before inhalation. Never wash the SEEBRI BREEZHALER inhaler with water. Keep it dry. See below How to clean your inhaler. Never take the SEEBRI BREEZHALER inhaler apart. Always keep the SEEBRI BREEZHALER inhaler and SEEBRI BREEZHALER capsules in a dry place. Avoid getting the drug powder in your eyes. Additional information Occasionally, very small pieces of the capsule can get past the screen and enter your mouth. If this happens, you may be able to feel these pieces on your tongue. It is not harmful if these pieces are swallowed or inhaled. The chances of the capsule shattering will be increased if the capsule is pierced more than once (step 7). How to clean your inhaler Never wash your inhaler with water. If you want to clean your inhaler, wipe the mouthpiece inside and outside with a clean, dry, lint-free cloth to remove any powder residue. Keep the inhaler dry. Overdose: If you think you have inhaled too much SEEBRI BREEZHALER, contact your doctor, nurse, pharmacist, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms. Missed Dose: If you forget to inhale a dose, inhale one as soon as possible but do not inhale two doses on the same day. Then inhale the next dose as usual. SIDE EFFECTS AND WHAT TO DO ABOUT THEM As with all medicines, patients using SEEBRI BREEZHALER may experience side effects, although not everybody gets them. Side effects may include: Upset stomach, indigestion Pain in extremities (e.g. arms or legs) Feeling of pressure or pain in the cheeks and forehead (possible symptoms of sinus congestion) SEEBRI BREEZHALER Consumer Information Page 4 of 6
5 Dry mouth Nausea, vomiting, diarrhea and abdominal pain (possible symptoms of gastroenteritis) Difficulty sleeping Symptoms of common cold (runny or stuffy nose, cough, sore throat, sneezing) Pain in muscles, bones or joints Cavities Rash Tiredness Weakness Throat irritation Nose bleeds Tingling or numbness Itching Some elderly patients above 75 years of age have also experienced headache and urinary tract infection. SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM Symptom / effect Uncommon New occurrence of irregular heart beat Increased blood sugar: Frequent urination, thirst, and hunger Difficulty and pain when passing urine, urinating frequently, urination in a weak stream or drips Glaucoma: New or worsened pressure in your eyes, eye pain or discomfort, blurred vision, seeing halos of bright colours around lights, red eyes Talk with your doctor, nurse, or pharmacist Only if severe In all cases Stop taking drug and seek immediate emergency medical help SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM Symptom / effect Unknown Paradoxical Bronchospasm: Tightness of the chest associated with coughing, wheezing, or breathlessness immediately after inhalation of SEEBRI BREEZHALER Allergic Reaction: rash, hives, swelling of the face, mouth, lips, throat and tongue, difficulty swallowing or breathing Talk with your doctor, nurse, or pharmacist Only if severe In all cases Stop taking drug and seek immediate emergency medical help This is not a complete list of side effects. For any unexpected effects while taking SEEBRI BREEZHALER, contact your doctor, nurse, or pharmacist. HOW TO STORE IT Do not use after the expiry date shown on the box. Store SEEBRI BREEZHALER at room temperature between 15 to 25 C. Store the capsules in the original package in a dry place in order to protect from heat and moisture. Do not remove capsules from the blister pack until immediately before use. Do not use this medicine if you notice that the pack is damaged or show signs of tampering. Each inhlaer should be disposed of after 30 days of use. Keep out of sight and reach of children. SEEBRI BREEZHALER Consumer Information Page 5 of 6
6 REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways: Report online at Call toll-free at Complete a Canada Vigilance Reporting Form and: - Fax toll-free to , or - Mail to: Canada Vigilance Program Health Canada Postal Locator 0701E Ottawa, Ontario K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect Canada Web site at NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice. MORE INFORMATION This document plus the product monograph, prepared for health professionals can be found at: or by contacting the sponsor, Novartis Pharmaceuticals Canada Inc., at: This leaflet was prepared by: Novartis Pharmaceuticals Canada Inc. 385, Bouchard Blvd., Dorval, Quebec H9S 1A9 Last revised: July 27, 2015 SEEBRI and BREEZHALER are registered trademarks SEEBRI BREEZHALER Consumer Information Page 6 of 6
ONBREZ BREEZHALER should only be used to treat COPD.
CONSUMER INFORMATION Pr ONBREZ BREEZHALER Indacaterol maleate This leaflet is part III of a three-part "Product Monograph" published when ONBREZ BREEZHALER was approved for sale in Canada and is designed
More informationPackage leaflet: Information for the user. Seebri Breezhaler 44 micrograms inhalation powder, hard capsules glycopyrronium (as glycopyrronium bromide)
Package leaflet: Information for the user Seebri Breezhaler 44 micrograms inhalation powder, hard capsules glycopyrronium (as glycopyrronium bromide) Read all of this leaflet carefully before you start
More informationULTIBRO BREEZHALER should only be used to treat COPD. ULTIBRO BREEZHALER should not be used to treat asthma.
PART III: CONSUMER INFORMATION Pr ULTIBRO BREEZHALER Indacaterol (as maleate)/glycopyrronium (as bromide) inhalation powder hard capsules Read this carefully before you start taking ULTIBRO BREEZHALER
More informationIMPORTANT: PLEASE READ
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr Spiriva Respimat Tiotropium Bromide Monohydrate Inhalation Solution Read this carefully before you start taking SPIRIVA RESPIMAT and each time you
More informationMEDICATION GUIDE ANORO ELLIPTA
MEDICATION GUIDE ANORO ELLIPTA [a-nor oh e-lip-ta] (umeclidinium and vilanterol inhalation powder) for oral inhalation What is the most important information I should know about ANORO ELLIPTA? ANORO ELLIPTA
More informationPATIENT INFORMATION INCRUSE ELLIPTA
PATIENT INFORMATION INCRUSE ELLIPTA [IN-cruise e-lip-ta] (umeclidinium inhalation powder) for oral inhalation What is INCRUSE ELLIPTA? INCRUSE ELLIPTA is an anticholinergic medicine. Anticholinergic medicines
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Onbrez Breezhaler 150 microgram inhalation powder, hard capsules Onbrez Breezhaler 300 microgram inhalation powder, hard capsules Indacaterol Read all of this
More informationOXEZE TURBUHALER formoterol fumarate dihydrate
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION OEZE TURBUHALER formoterol fumarate dihydrate This leaflet is part III of a three-part Product Monograph published when OEZE TURBUHALER was approved
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr ANORO ELLIPTA umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation This leaflet is part III of a three-part "Product Monograph" published
More informationPackage leaflet: Information for the patient. Eklira Genuair 322 micrograms inhalation powder Aclidinium (aclidinium bromide)
Package leaflet: Information for the patient Eklira Genuair 322 micrograms inhalation powder Aclidinium (aclidinium bromide) This medicine is subject to additional monitoring. This will allow quick identification
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION ARNUITY ELLIPTA fluticasone furoate dry powder for oral inhalation This leaflet is part III of a three-part "Product Monograph" published when ARNUITY ELLIPTA was approved
More informationOXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION OEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation This leaflet is part III of a three-part Product Monograph published when
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr ANORO ELLIPTA umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation This leaflet is part III of a three-part "Product Monograph" published
More informationhydrochloride) from the mouthpiece. PART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr Inspiolto Respimat Tiotropium (as Tiotropium Bromide Monohydrate) / Olodaterol (as Olodaterol Hydrochloride) Inhalation Solution Read this carefully before you start taking
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] Mepolizumab for Injection Read this carefully before you start taking NUCALA and each time you
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr ANORO ELLIPTA umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation This leaflet is part III of a three-part "Product Monograph" published
More informationIMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION
IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION DUAKLIR GENUAIR aclidinium bromide/ formoterol fumarate dihydrate inhalation powder This leaflet is part III of a three-part "Product Monograph" published
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr AVAMYS fluticasone furoate nasal spray FOR NASAL USE ONLY This leaflet is part III of a three-part "Product Monograph" published when AVAMYS was approved for sale in Canada
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each
More informationIpratrin uni-dose Ipratrin Adult uni-dose contains the active ingredient ipratropium bromide Consumer Medicine Information
Ipratrin uni-dose Ipratrin Adult uni-dose contains the active ingredient ipratropium bromide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Ipratrin
More informationCOMBIVENT UDV Product Monograph Page 35 of 39
PART III: CONSUMER INFORMATION Pr Combivent UDV Ipratropium Bromide (as Monohydrate) and Salbutamol (as Salbutamol Sulfate) Nebulizer Solution Read this carefully before you start taking COMBIVENT UDV
More informationPRODUCT MONOGRAPH. Pr KYTRIL. granisetron hydrochloride tablets. 1 mg granisetron as hydrochloride. Manufacture Standard
PRODUCT MONOGRAPH Pr KYTRIL granisetron hydrochloride tablets 1 mg granisetron as hydrochloride Manufacture Standard Antiemetic (5-HT 3 receptor antagonist) Hoffmann-La Roche Limited Date of Revision:
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr BACLOFEN Baclofen Tablets 10 mg and 20 mg This leaflet is part III of a three-part "Product Monograph" published when BACLOFEN was approved for sale in Canada and is designed
More informationVentolin Accuhaler 200 micrograms salbutamol sulfate
Package Leaflet: Information for the User Ventolin Accuhaler 200 micrograms salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for
PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr SYLVANT pronounced SILL-vant siltuximab for injection Read this carefully before you start taking SYLVANT and each
More informationGuide for Patients & Caregivers
Pr ALERTEC * Modafinil Tablets 100 mg Central Nervous System Stimulant Guide for Patients & Caregivers ALERTEC is manufactured by: Teva Canada Limited Toronto, Ontario M1B 2K9 ALERTEC is distributed by:
More informationUltibro Breezhaler. Good to know about. Medicine for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Good to know about Ultibro Breezhaler Medicine for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) Information for those who have been prescribed Ultibro For further information read the
More informationPATIENT INFORMATION RELENZA
PATIENT INFORMATION RELENZA (ruh-lens-uh) (zanamivir inhalation powder) for oral inhalation use What is RELENZA? RELENZA is a prescription medicine used to: treat the flu (influenza A and B virus) in people
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION ALPROLIX [pronounced all prō liks] Coagulation Factor IX (Recombinant), Fc Fusion Protein This leaflet is part III of a three-part "Product Monograph" published when ALPROLIX
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER FORMAXA AXAHALER 12 micrograms/dose, inhalation powder, hard capsule (formoterol fumarate) Read all of this leaflet carefully before you start using this medicine.
More informationSpiriva Respimat. What is in this leaflet. Before you use Spiriva Respimat. What Spiriva Respimat is used for
Spiriva Respimat Solution for Inhalation Tiotropium Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Spiriva Respimat. It does not contain all
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION Pr TALTZ ixekizumab www.lilly.ca Lilly Read this carefully before you start taking TALTZ and each time you
More informationBeclazone 50, 100, 250 micrograms CFC-Free Inhaler
NEW ZEALAND CONSUMER MEDICINE INFORMATION Beclazone 50, 100, 250 micrograms CFC-Free Inhaler Beclometasone dipropionate 50, 100, or 250 micrograms per metered dose ( puff ) Please read this leaflet carefully
More informationAtrovent Metered Aerosol (CFC Free)
Atrovent Metered Aerosol (CFC Free) Ipratropium bromide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Atrovent Metered Aerosol. It does not contain
More informationPATIENT MEDICATION INFORMATION
- 1 - READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION TENORMIN atenolol tablets Read this carefully before you start taking TENORMIN and each time you get a refill.
More informationPRODUCT MONOGRAPH TARCEVA. erlotinib hydrochloride tablets. erlotinib 25, 100, 150 mg
PRODUCT MONOGRAPH Pr TARCEVA erlotinib hydrochloride tablets erlotinib 25, 100, 150 mg Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Protein Kinase Inhibitor (L01XE03) Hoffmann-La Roche
More informationPatient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA?
Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA? ARNUITY ELLIPTA is an inhaled corticosteroid (ICS) medicine
More informationPackage leaflet: Information for the patient. Duaklir Genuair 340 micrograms /12 micrograms inhalation powder aclidinium/formoterol fumarate dihydrate
Package leaflet: Information for the patient Duaklir Genuair 340 micrograms /12 micrograms inhalation powder aclidinium/formoterol fumarate dihydrate This medicine is subject to additional monitoring.
More informationOXIS TURBUHALER Formoterol fumarate dihydrate for inhalation
OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Oxis Turbuhaler. It does not contain
More informationDorzolamide 20 mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationPackage leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide
Package leaflet: Information for the user Pulmicort Respules 0.5 mg, Nebuliser Suspension budesonide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationEasyhaler Beclometasone 200 micrograms/dose inhalation powder
Package Leaflet: Information for the user Easyhaler Beclometasone 200 micrograms/dose inhalation powder Beclometasone dipropionate Read all of this leaflet carefully before you start using this medicine
More informationPART III: CONSUMER INFORMATION XOLAIR (omalizumab)
PART III: CONSUMER INFORMATION XOLAIR (omalizumab) This leaflet is part III of a three-part "Product Monograph" published when XOLAIR was approved for sale in Canada and is designed specifically for Consumers.
More informationPATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation
PATIENT INFORMATION ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is ADVAIR DISKUS? ADVAIR DISKUS combines the inhaled corticosteroid
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION Pr CHAMPI (varenicline tartrate tablets) Read this information each time you refill your prescription in case new information has been added. This leaflet is part III of
More informationSANDOMIGRAN. 0.5mg tablet Pizotifen malate
SANDOMIGRAN 0.5mg tablet Pizotifen malate What is in this leaflet This leaflet answers some common questions about Sandomigran. It does not contain all the available information. It does not take the place
More information1 What Flixotide is and what it is used for
GSK Logo Package Leaflet: Information for the user Flixotide Diskus 50 micrograms, 100 micrograms, 250 micrograms, 500 micrograms Inhalation Powder, pre-dispensed (fluticasone propionate) Read all of this
More informationLECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018
PRODUCT MONOGRAPH LECTOPAM bromazepam 3 mg and 6 mg Tablets Anxiolytic - Sedative Hoffmann-La Roche Limited 7070 Mississauga Road Mississauga, Ontario L5N 5M8 Date of Revision: September 6, 2018 www.rochecanada.com
More informationFlixotide Accuhaler 50 micrograms, 100 micrograms, 250 micrograms, 500 micrograms
Package Leaflet: Information for the user Flixotide Accuhaler 50 micrograms, 100 micrograms, 250 micrograms, 500 micrograms fluticasone propionate Read all of this leaflet carefully before you start taking
More informationPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ALECENSARO. alectinib (as alectinib hydrochloride) Capsule, 150 mg
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr ALECENSARO alectinib (as alectinib hydrochloride) Capsule, 150 mg Protein Kinase Inhibitor (L01XE) Hoffmann-La Roche Limited 7070 Mississauga
More informationPART III: PATIENT MEDICATION INFORMATION. CLINDAMYCINE-150 Pr. CLINDAMYCINE-300 (Clindamycin Hydrochloride Capsules USP) Clindamycin 150 mg and 300 mg
PART III: PATIENT MEDICATION INFORMATION Pr CLINDAMYCINE-150 Pr CLINDAMYCINE-300 (Clindamycin Hydrochloride Capsules USP) Clindamycin 150 mg and 300 mg Read this carefully before you start taking CLINDAMYCINE
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationWhat is in this leaflet. Before you use BREO ELLIPTA. What BREO ELLIPTA is used for. When you must not use it
BREO Fluticasone furoate 100 or 200 micrograms and vilanterol (as trifenatate) 25 micrograms per inhalation New Zealand Consumer Medicine Information What is in this leaflet Please read this leaflet carefully
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder, hard capsules indacaterol/glycopyrronium This medicine is subject to additional monitoring. This
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. APO-SALVENT CFC FREE salbutamol sulphate inhalation aerosol
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION APO-SALVENT CFC FREE salbutamol sulphate inhalation aerosol Read this carefully before you start taking APO-SALVENT
More informationCeclor CD cefaclor monohydrate sustained release tablets
Ceclor CD cefaclor monohydrate sustained release tablets Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Ceclor CD. It does not contain all
More informationINFORMATION FOR THE CONSUMER
INFORMATION FOR THE CONSUMER TRANSDERM-V* and HOW TO USE IT (scopolamine) Transdermal Therapeutic System INTRODUCTION This leaflet is intended to help you understand what TRANSDERM-V* is and how it helps
More informationPATIENT INFORMATION LEAFLET CARZIN XL
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: 4 mg film coated tablets. Read all of this leaflet carefully before you start taking. Keep this leaflet. You may need to read it
More informationPATIENT INFORMATION BREO ELLIPTA
PATIENT INFORMATION BREO ELLIPTA [BRE-oh e-lip-ta] (fluticasone furoate and vilanterol inhalation powder) for oral inhalation What is BREO ELLIPTA? BREO ELLIPTA combines an inhaled corticosteroid (ICS)
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Buscopan Hyoscine Butylbromide Injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Buscopan Hyoscine Butylbromide Injection Read this carefully before you start taking BUSCOPAN. This leaflet is a summary
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION SPINRAZA nusinersen injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION SPINRAZA nusinersen injection Read this carefully before you or your child start receiving SPINRAZA and before each
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION A Notice of Compliance with Conditions (NOC/c) is a type of approval to sell a drug in Canada. IBRANCE is used: -along
More informationHow Entecavir GH Works
entecavir monohydrate tablets ENTECAVIR GH Tablets Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking. This leaflet answers some common questions about. It
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION APO-TRIAMCINOLONE AQ Children 4 to 12 years Triamcinolone Acetonide Aqueous Nasal Spray 55 mcg/metered Spray Apotex Standard This leaflet is part III of a three-part Product
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP)
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr Sandoz Omeprazole (omeprazole delayed release capsules USP) Read this carefully before you start taking Sandoz Omeprazole
More informationPackage leaflet: Information for the user. Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium
Package leaflet: Information for the user Colobreathe 1,662,500 IU inhalation powder, hard capsules Colistimethate sodium Read all of this leaflet carefully before you start using this medicine because
More informationPRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)
PRODUCT MONOGRAPH Pr TAMIFLU oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate) oseltamivir powder for oral suspension 6 mg/ml oseltamivir (as oseltamivir phosphate) when
More informationFLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation
FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation Consumer Medicine Information Please read this leaflet carefully before you start taking Flixotide What is in this leaflet?
More informationPHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET
PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL
More informationPART III: CONSUMER INFORMATION
PART III: CONSUMER INFORMATION Pr DYMISTA (Azelastine hydrochloride and fluticasone propionate, Nasal Spray) This leaflet is part III of a three-part "Product Monograph" published when DYMISTA was approved
More informationMEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol
MEDICATION GUIDE ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol ADVAIR HFA 115/21 (fluticasone propionate 115 mcg and salmeterol 21 mcg) Inhalation
More informationKAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER KAMIREN 2 mg, 4 mg TABLETS DOXAZOSIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationAtrovent. What is in this leaflet. Before you use Atrovent Metered Aerosol. What Atrovent Metered Aerosol is used for
Atrovent Metered Aerosol (CFC Free) Ipratropium bromide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Atrovent Metered It does not contain all the
More informationDo not use Easyhaler Salbutamol if you are allergic (hypersensitive) to: Salbutamol lactose
Package leaflet: Information for the patient user Easyhaler Salbutamol Sulphate 100 and 200 micrograms/dose inhalation powder Salbutamol sulphate (salbutamol) Read all of this leaflet carefully before
More informationBrimica Genuair 340/12 Powder for inhalation aclidinium (as bromide)/eformoterol fumarate dihydrate
Brimica Genuair 340/12 Powder for inhalation aclidinium (as bromide)/eformoterol fumarate dihydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. PRINIVIL (lisinopril tablets, Merck Standard)
44 READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION PRINIVIL (lisinopril tablets, Merck Standard) Read this carefully before you start taking PRINIVIL and each time
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. ERYC Erythromycin delayed release capsules USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ERYC Erythromycin delayed release capsules USP Read this carefully before you start taking ERYC and each time you get
More informationPackage Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride
Package Leaflet: Information for the User Kemadrin tablets 5 mg procyclidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPOLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS
PROPOSED FINAL PATIENT INFORMATION LEAFLET FOR POLLENTYME TABLETS & POLLENTYME S PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS
More informationBeclazone CFC-Free Inhaler
NEW ZEALAND CONSUMER MEDICINE INFORMATION Beclazone CFC-Free Inhaler Beclometasone dipropionate 50, 100, or 250 micrograms per metered dose ( puff ) Please read this leaflet carefully before you start
More informationPATIENT MEDICATION INFORMATION. MEGACE OS Megestrol acetate Oral Suspension
PATIENT MEDICATION INFORMATION MEGACE OS Megestrol acetate Oral Suspension Read this carefully before you start taking MEGACE OS and each time you get a refill. This leaflet is a summary and will not tell
More informationIMPORTANT: PLEASE READ
PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate
PACKAGE LEAFLET: INFORMATION FOR THE USER Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationPATIENT INFORMATION LEAFLET TEXAMER
SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,
More informationPATIENT INFORMATION LEAFLET SINTAIR RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: SINTAIR 4 mg (chewable tablets) SINTAIR 5 mg (chewable tablets) SINTAIR 10 mg (tablets) Please read this leaflet carefully before
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage Leaflet: Information for the user. RELENZA 5 mg per dose, inhalation powder, pre-dispensed zanamivir
Package Leaflet: Information for the user RELENZA 5 mg per dose, inhalation powder, pre-dispensed zanamivir Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the user Formoterol Easyhaler 12 micrograms/dose inhalation powder formoterol fumarate dihydrate
Package leaflet: Information for the user Formoterol Easyhaler 12 micrograms/dose inhalation powder formoterol fumarate dihydrate Read all of this leaflet carefully before you start using this medicine
More informationPATIENT INFORMATION LEAFLET POLLENTYME S AND TABS
SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information
More informationPilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LIPIDIL EZ. fenofibrate, NanoCrystal formulation tablets
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION LIPIDIL EZ fenofibrate, NanoCrystal formulation tablets Read this carefully before you start taking LIPIDIL EZ and each
More informationXYZAL 5 MG FILM-COATED TABLET
XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. Palbociclib Capsules
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IBRANCE Palbociclib Capsules Read this carefully before you start taking IBRANCE and each time you get a refill.
More informationColofac mebeverine hydrochloride
Colofac mebeverine hydrochloride Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Colofac. It does not contain all the available information.
More information